Gene hunt aims to prevent deadly diabetes drug complication
NCT ID NCT05402579
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study looked at the genes of 63 people with type 2 diabetes to see if certain DNA variations could predict who is at risk for diabetic ketoacidosis (DKA) when taking SGLT2 inhibitors. Researchers compared the DNA of people who had DKA while on the drug to those who did not. The goal is to help doctors identify who can safely use these life-saving drugs and who might need extra monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Joseph's Health Centre (Unity Health Toronto)
Toronto, Ontario, Canada
-
Toronto General Hospital (University Health Network)
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.